Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cerebrospinal fluid amyloid beta(40) is decreased in cerebral amyloid angiopathy.

Annals of neurology - 1 Aug 2009

Verbeek Marcel M, Kremer Berry P H, Rikkert Marcel Olde, Van Domburg Peter H M F, Skehan Maureen E, Greenberg Steven M

Abstract excerpt

Cerebral amyloid angiopathy is caused by deposition of the amyloid beta protein in the cerebral vasculature. In analogy to previous observations in Alzheimer disease, we hypothesized that analysis of amyloid beta(40) and beta(42) proteins in the cerebrospinal fluid might serve as a molecular biomarker. We observed strongly decreased cerebrospinal fluid amyloid beta(40) (p < 0.01 vs controls or Alzheimer disease)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyloid beta-Peptides
Share to Area Under Curve

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cerebral Amyloid Angiopathy

Share to Diagnosis, Differential

Share to Enzyme-Linked Immunosorbent Assay

Share to Peptide Fragments

Share to ROC Curve

Share to tau Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 19743453
DOI: 10.1002/ana.21694
PMCID: PMC3697750

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cerebrospinal fluid amyloid beta(40) is decreased in cerebral amyloid angiopathy.PMID 19743453Read ↗

Increased cerebrospinal fluid A beta38/A beta42 ratio in Alzheimer disease.Semantic proximity Read ↗

Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.Semantic proximity Read ↗

Cerebrospinal fluid tau, p-tau 181 and amyloid-β38/40/42 in frontotemporal dementias and primary progressive aphasias.Semantic proximity Read ↗

Plasma and Cerebrospinal Fluid Levels of Amyloid β Proteins 1-40 and 1-42 in Alzheimer DiseaseSemantic proximity Read ↗

Cerebrospinal Fluid Biomarkers Profiling in Cerebral Amyloid Angiopathy and Relationship With Disease Phenotypes.Semantic proximity Read ↗

Cerebral amyloid angiopathy.Semantic proximity Read ↗

Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease.Semantic proximity Read ↗

Amyloid beta protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease.Semantic proximity Read ↗

Neurodegenerative disease biomarkers Aβ1–40, Aβ1–42, tau, and p‐tau181 in the vervet monkey cerebrospinal fluid: Relation to normal aging, genetic influences, and cerebral amyloid angiopathySemantic proximity Read ↗

Comparative analytical performance of multiple plasma Aβ42 and Aβ40 assays and their ability to predict positron emission tomography amyloid positivity.Semantic proximity Read ↗

Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to beta-amyloid peptide42.Semantic proximity Read ↗

Decreased beta-amyloid peptide42 in cerebrospinal fluid of patients with progressive supranuclear palsy and corticobasal degeneration.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.